文献速递功能神经外科脊柱脊髓外科

脊髓电刺激治疗慢性疼痛可减少阿片类药物使用,未使用阿片类药物时临床结局更优

Spinal Cord Stimulation for the Treatment of Chronic Pain Reduces Opioid Use and Results in Superior Clinical Outcomes When Used Without Opioids.
PubMed 文献 · Neurosurgery · 2019-01-01

这项前瞻性队列研究纳入2012年9月至2015年8月接受脊髓电刺激(SCS)手术治疗慢性疼痛的86例患者,评估SCS是否减少阿片类药物使用并单独维持疼痛与心理社会健康结局指标。53例术前使用阿片类药物,33例未使用;未使用者1年时平均VAS、NRS和ODI评分低于两个阿片类药物组,且VAS(P < .001)、NRS(P < .001)、MPQ(P = .002)、PCS(P < .001)、BDI(P = .04)、ODI(P = .002)均显著改善。术后41.5%仍使用阿片类药物,58.5%减少或停止使用;停用(n = 29)或减少(n = 2)使用使VAS、NRS、MPQ总分和ODI评分下降(分别为P < .001、P = .002、P = .002、P = .009)。1年时仍使用阿片类药物者问卷评分无变化,两组翻修率或失败率无差异。

要点

  • SCS术前使用阿片类药物的53例中,术后1年58.5%减少或停用(停用n = 29,减少n = 2)。
  • 未使用阿片类药物的33例1年时VAS、NRS、ODI评分低于两个阿片类药物组,且多项指标显著改善。
  • 1年时仍使用阿片类药物者问卷评分无变化,两组翻修率或失败率无差异。

核心结论

  • SCS术前使用阿片类药物的患者中,64%在术后1年减少(n = 2)或停用(n = 29)阿片类药物。
  • 停用阿片类药物或从未使用阿片类药物的患者,临床结局优于继续使用者。

研究设计与样本

  • 前瞻性队列研究,纳入2012年9月至2015年8月因慢性疼痛接受SCS手术的86例患者。
  • 术前和术后完成NRS、MPQ、PCS、ODI和BDI评估,VAS评分进行回顾性分析。

主要发现

  • 53例在SCS植入前使用阿片类药物,33例未使用。
  • 未使用者1年时平均VAS、NRS和ODI评分低于两个阿片类药物组,且1年时VAS(P < .001)、NRS(P < .001)、MPQ(P = .002)、PCS(P < .001)、BDI(P = .04)、ODI(P = .002)显著改善。
  • 术后41.5%仍使用阿片类药物,58.5%减少或停用。
  • 停用(n = 29)或减少(n = 2)使用使VAS、NRS、MPQ总分和ODI评分下降(分别为P < .001、P = .002、P = .002、P = .009)。
  • 1年时仍使用阿片类药物者问卷评分无变化,两组翻修率或失败率无差异。

临床怎么用

  • 作者结论认为,停用阿片类药物或从未使用阿片类药物的患者临床结局优于继续使用者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic pain causes a significant burden to the US health care system, is difficult to treat, and remains a significant contributor to increased opioid use in the United States. Spinal cord stimulation (SCS) has been FDA approved for the treatment of chronic pain. OBJECTIVE: To evaluate the hypothesis that SCS reduces opioid use, and alone maintains clinical outcome measures of pain and psychosocial determinants of health. METHODS: In this prospective cohort study, we evaluated 86 patients undergoing SCS surgery for the treatment of chronic pain between September 2012 and August 2015. Preoperatively and postoperatively, patients completed the Numerical Rating Scale (NRS), McGill Pain Questionnaire (MPQ), Pain Catastrophizing Scale (PCS), Oswestry Disability Index (ODI), and Beck's Depression Inventory (BDI). VAS scores were retrospectively analyzed. RESULTS: Fifty-three patients used opioids before SCS implantation. The 33 nonusers had lower mean VAS, NRS, and ODI scores than both opioid groups at 1 yr and improved significantly at 1 yr on the VAS (P < .001), NRS (P < .001), MPQ (P = .002), PCS (P < .001), BDI (P = .04), and ODI (P = .002). After surgery, 41.5% remained opioids and 58.5% reduced/eliminated use. Discontinued (n = 29) or reduced (n = 2) use resulted in VAS, NRS, total MPQ, and ODI score reduction (P < .001, P = .002, P = .002, and P = .009 respectively). At 1 yr, survey scores in opioid users were unchanged. There was no difference between groups in revision or failure rates. CONCLUSION: Sixty-four percent of patients who were using opioids prior to SCS reduced (n = 2) or eliminated opioid use (n = 29) at 1 yr postoperatively. Patients who eliminated opioid use or never used opioids had superior clinical outcomes to those who continued use.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Gee L, Smith HC, Ghulam-Jelani Z, et al. Spinal Cord Stimulation for the Treatment of Chronic Pain Reduces Opioid Use and Results in Superior Clinical Outcomes When Used Without Opioids. Neurosurgery. 2019. PMID: 29538696. doi:10.1093/neuros/nyy065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。